Laboratorios Bagó de Colombia is a pharmaceutical company that began operations in the country following the acquisition of Compañía Farmacéutica Química Ariston. Since its inception, the company has implemented an ambitious work plan that has enabled it to establish itself as one of the most prominent organizations in the healthcare sector in Colombia. Its management is characterized by a remarkable ability to adapt to environmental challenges, while consistently maintaining sustained growth supported by a solid international industrial structure of 11 production facilities.
Commercial offices
Pharmaceutical plant
IQVIA 69th RANKING
30 REPS
4% GOVERNMENT SALES
96% RETAIL SALES
NEWS
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
Based on production quality, research and development, and the efficiency of its technical and commercial service, Biogénesis – Bagó has become an international leader in animal health.
The distribution of pharmaceuticals is a key factor of this industry and a competitve advantage of the Bagó Group, with 3 distributors strategically located in Latin America and equipped with state-of-the-art technology.
Victoria Seguros, is a solid and responsible insurance company, with a vast track record and high reputation in the market. It offers a wide range of top quality products.
The pharmochemical production of active pharmaceutical ingredients from chemical inputs is carried out at the Grupo Bagó industrial plant, specifically designed for these types of processes.
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
Based on production quality, research and development, and the efficiency of its technical and commercial service, Biogénesis – Bagó has become an international leader in animal health.
The distribution of pharmaceuticals is a key factor of this industry and a competitve advantage of the Bagó Group, with 3 distributors strategically located in Latin America and equipped with state-of-the-art technology.
Victoria Seguros, is a solid and responsible insurance company, with a vast track record and high reputation in the market. It offers a wide range of top quality products.
The pharmochemical production of active pharmaceutical ingredients from chemical inputs is carried out at the Grupo Bagó industrial plant, specifically designed for these types of processes.
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness